Efficacy, Safety, and Early Relapse after Cessation of Upadacitinib versus Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis®: A Real-World Study in China
1. 系统已在2026-03-31 12:10:28对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
文献链接: https://journals.sagepub.com/doi/10.1089/derm.2024.0014
其他信息:
出版社: SAGE Publications
作者: Jiling Zhu; Hanwen Wu; Yahui Ye; Qiuyang Xu; Junyi Shao; Zicheng Bai; Yiwen Zhou; Zhenyan Li; Jingjing Liu; Zhiming Li
全文下载地址: https://journals.sagepub.com/doi/pdf/10.1089/derm.2024.0014

